Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group.
Ronceray L, et al. Among authors: attarbaschi a.
Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26932. Epub 2017 Dec 29.
Pediatr Blood Cancer. 2018.
PMID: 29286565
Clinical Trial.